lub1 Antibody

Shipped with Ice Packs
In Stock

Description

LGI1 Antibodies (Limbic Encephalitis and Epilepsy)

Source: (2020)
LGI1 (leucine-rich glioma inactivated 1) antibodies are associated with autoimmune limbic encephalitis and seizures. Key findings include:

  • Binding Specificities: Patient-derived monoclonal antibodies (mAbs) target either the LRR (leucine-rich repeat) or EPTP (epitempin repeat) domains of LGI1.

  • Pathogenic Mechanisms:

    • LRR-specific mAbs:

      • Bind tightly to LGI1-ADAM22/23 complexes, inducing internalization in neurons.

      • Disrupt synaptic function by downregulating AMPA receptors and Kv1.1 channels.

    • EPTP-specific mAbs:

      • Inhibit LGI1-ADAM22/23 interactions but show weaker binding to rodent brain sections.

Antibody TypeBinding DomainBrain BindingFunctional Impact
LRR-specificLRRStrongSynaptic disruption
EPTP-specificEPTPWeakInhibits interactions

Clinical Relevance: IgG4 subclass dominates in patient sera, suggesting chronic immune activation .

Lub1 (Fission Yeast Ubiquitin Regulator)

Source: (2004)
Lub1 is a conserved protein in Schizosaccharomyces pombe regulating ubiquitin homeostasis. Key functions:

  • Ubiquitin Stabilization: Prevents excessive degradation of ubiquitin via negative regulation.

  • Stress Response: Interacts with Cdc48 (a chaperon-like ATPase) to maintain cellular stress resilience.

Phenotypic Defects in lub1 MutantsObserved Effects
Ubiquitin depletionHypersensitivity to heat/UV
Protein degradation defectsAccelerated ubiquitin turnover
Cellular morphologyEnlarged, round cells

Mechanistic Insight: Overexpression of ubiquitin genes rescues mutant phenotypes, confirming Lub1’s role in post-transcriptional ubiquitin regulation .

Lutheran Blood Group Antibodies (Anti-Lua/Lub)

Sources: , , (2019–2023)
The Lutheran system involves two primary antigens (Lua and Lub) on red cell glycoproteins (Lu/BCAM). Key characteristics:

  • Antibody Types:

    • Anti-Lua: Most common; IgM predominant, with IgG/IgA components.

    • Anti-Lub: Less frequent; often associated with other antibodies.

  • Clinical Impact:

    • Hemolytic Transfusion Reactions: Mild delayed reactions due to IgG subclass antibodies .

    • Genetic Variants: In(Lu) suppressor phenotype linked to KLF1 mutations .

Blood Group PhenotypeAntigen ExpressionAntibody Reactivity
Lu(a-b+)Lua dominantAnti-Lua
Lu(a-b-)Null phenotypeAnti-Lu3 (broad reactivity)

Immunoblotting Data: Anti-Lub monoclonal antibodies (e.g., clone 1E3) identify 85–78 kDa glycoproteins dependent on N-glycosylation and disulfide bonds .

Source: (2025)

  • Therapeutic Use: Intra-articular injection for osteoarthritis (OA) treatment.

  • Pharmacokinetics:

    • Half-lives: 4.5 h (alpha), 1.5 days (beta), 2.1 weeks (gamma).

    • Tissue Retention: Detectable on cartilage up to 28 days post-injection.

Efficacy in Rat OA Model
Cartilage DegradationReduced by 50% (vs. vehicle)
Pain ScoresImproved by 70%

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
lub1 antibody; SPBC887.04cUbiquitin homeostasis protein lub1 antibody
Target Names
lub1
Uniprot No.

Target Background

Function
Lub1 Antibody acts as a negative regulator of vacuole-dependent ubiquitin degradation.
Database Links
Subcellular Location
Nucleus. Cytoplasm.

Q&A

What is lub1 and what biological processes is it involved in?

Lub1 is a highly conserved 713-amino-acid protein in Schizosaccharomyces pombe (fission yeast) that functions as a homologue of Ufd3p/Zzz4p/Doa1p in budding yeast. It plays a critical role in the posttranscriptional regulation of cellular ubiquitin contents and stress responses .

Specifically, lub1 participates in:

  • Maintenance of ubiquitin homeostasis at the protein level

  • Negative regulation of ubiquitin degradation

  • Ubiquitin/proteasome-dependent proteolysis

  • Cellular responses to various stress conditions

Disruption of the lub1+ gene results in monoubiquitin and multiubiquitin depletion without changes in mRNA levels, leading to hypersensitivity to various stress conditions including UV irradiation, high temperature, calcium stress, and oxidative stress .

How is lub1 protein structurally characterized and what domains are important for antibody targeting?

Lub1 contains conserved domains that are critical for its function and can serve as important epitopes for antibody development:

  • WD domain: Essential for the stability of Lub1, likely through its interaction with Cdc48 . This domain forms a β-propeller structure that could serve as an important antigenic determinant.

  • N-terminal region (amino acids 1-279): Contains the WD domain and has been specifically studied through truncation experiments .

  • C-terminal region (amino acids 230-713): Contains functional domains that might serve as potential antibody targets.

When designing antibodies against lub1, these structural features should be considered to ensure optimal recognition of the target protein in its native conformation.

What are the typical applications for lub1 antibodies in research?

Lub1 antibodies can be valuable tools for studying ubiquitin regulation pathways in lower and potentially higher eukaryotes. Key applications include:

  • Protein localization studies: Determining the subcellular distribution of lub1 in fission yeast and potentially in mammalian homologues

  • Protein interaction studies: Investigating interactions between lub1 and its partners, particularly Cdc48

  • Expression level analysis: Monitoring lub1 protein levels during stress responses and other cellular conditions

  • Functional studies: Examining the role of lub1 in ubiquitin homeostasis and stress response pathways

  • Comparative studies: Investigating functional conservation between lub1 and its homologues in other organisms

How can lub1 antibodies be used to investigate ubiquitin homeostasis mechanisms?

Lub1 antibodies provide a valuable tool for investigating the molecular mechanisms underlying ubiquitin homeostasis:

  • Co-immunoprecipitation experiments: These can be designed to identify proteins that interact with lub1 during ubiquitin regulation. Protocol approach:

    • Lyse cells under non-denaturing conditions

    • Pre-clear lysates with protein A/G beads

    • Incubate with lub1 antibody (optimally 2-5 μg per mg of protein)

    • Precipitate antibody-protein complexes with protein A/G beads

    • Analyze interacting partners by mass spectrometry or Western blotting

  • Chromatin immunoprecipitation (ChIP): If lub1 has any role in transcriptional regulation of ubiquitin or related genes, ChIP using lub1 antibodies can map its genomic binding sites.

  • Immunofluorescence microscopy: To track changes in lub1 localization during stress responses, which could provide insights into its regulatory mechanisms.

  • Proximity labeling: Using engineered lub1 fusion proteins with proximity labeling enzymes (BioID, APEX) combined with lub1 antibodies for verification to identify transient or weak interactors in the ubiquitin regulation pathway.

What experimental designs can elucidate lub1's role in stress response pathways?

The research documented in shows that lub1-deleted cells display hypersensitivity to various stress conditions. Advanced experimental approaches using lub1 antibodies could include:

  • Temporal proteomic analysis:

    • Subject cells to different stressors (UV, heat, oxidative agents)

    • Collect samples at various time points (0, 15, 30, 60, 120 minutes)

    • Immunoprecipitate lub1 and analyze associated proteins

    • Monitor changes in lub1 post-translational modifications

  • Sub-cellular fractionation:

    • Separate cytoplasmic, nuclear, and membrane fractions

    • Quantify lub1 distribution across fractions using the antibody

    • Track re-localization of lub1 under different stress conditions

  • Proteasome activity assays:

    • Compare proteasome activity in wild-type versus lub1-depleted cells

    • Use lub1 antibodies to immunodeplete the protein from extracts

    • Analyze effects on ubiquitin-dependent proteolysis

How can researchers distinguish between functional domains of lub1 using domain-specific antibodies?

Domain-specific lub1 antibodies can be powerful tools for dissecting protein function:

  • Epitope mapping strategy:

    • Generate antibodies against WD domain (amino acids 1-279)

    • Generate antibodies against C-terminal region (amino acids 230-713)

    • Confirm specificity using recombinant domain fragments

  • Domain blockade experiments:

    • Use domain-specific antibodies to potentially block interactions

    • Compare effects of blocking different domains on lub1 function

    • Measure impact on ubiquitin levels and stress responses

  • Conformational studies:

    • Employ conformation-specific antibodies that recognize lub1 in different states

    • Monitor conformational changes under stress conditions

    • Correlate with functional outcomes

Domain-specific antibodies would be especially valuable for investigating the specific roles of the WD domain, which appears critical for lub1 stability through its interaction with Cdc48 .

What are the optimal strategies for generating highly specific lub1 antibodies?

Developing specific antibodies against lub1 requires careful consideration of several factors:

  • Antigen design options:

    • Full-length recombinant lub1 protein

    • Synthetic peptides from unique, surface-exposed regions

    • Domain-specific fragments (WD domain or C-terminal region)

  • Host selection considerations:

    • Rabbits: Good for polyclonal antibodies with high affinity

    • Mice/rats: Suitable for monoclonal antibody development

    • Chickens: Useful for generating antibodies against highly conserved proteins

  • Validation approach:

    • Western blot analysis using wild-type and lub1-deleted yeast strains

    • Immunoprecipitation followed by mass spectrometry

    • Immunofluorescence comparison between wild-type and mutant cells

  • Advanced library design:
    Recent advances in antibody library design using computational methods as described in can be leveraged to develop highly specific antibodies against lub1. This approach combines:

    • Deep learning predictions of mutation effects

    • Integer linear programming optimization

    • Diversity constraints to ensure broad epitope coverage

What validation tests should be performed to confirm lub1 antibody specificity?

A comprehensive validation strategy should include:

  • Primary validation tests:

    • Western blotting using lub1-knockout cells as negative controls

    • Peptide competition assays to confirm epitope specificity

    • Immunoprecipitation followed by mass spectrometry identification

  • Secondary validation tests:

    • Immunofluorescence microscopy comparing wild-type and lub1-deleted cells

    • Cross-reactivity testing against closely related proteins

    • Dot blot analysis with purified recombinant lub1 protein

  • Functional validation:

    • Antibody microinjection to test for functional interference

    • Validation in heterologous expression systems

    • Correlation of signal intensity with known lub1 expression patterns

Validation MethodTechnical ApproachExpected Outcome for Specific Antibody
Western BlotCompare wild-type vs. Δlub1 lysatesSingle band at 713aa (~78 kDa) in wild-type, absent in Δlub1
ImmunoprecipitationPull-down from wild-type lysate followed by MSIdentification of lub1 and known interactors (e.g., Cdc48)
Peptide CompetitionPre-incubate antibody with immunizing peptideSignal diminution or elimination
ImmunofluorescenceCompare staining in wild-type vs. Δlub1 cellsCytoplasmic and nuclear staining in wild-type, absent in Δlub1

What are the best methods for using lub1 antibodies in co-immunoprecipitation studies with Cdc48?

Given that lub1 interacts with Cdc48 through its WD domain , co-immunoprecipitation (co-IP) studies are particularly relevant:

  • Optimal lysis conditions:

    • Use non-denaturing lysis buffers (e.g., 50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EDTA)

    • Include protease inhibitors and deubiquitinase inhibitors

    • Maintain samples at 4°C throughout to preserve protein-protein interactions

  • Co-IP protocol optimization:

    • Cross-titrate lub1 and Cdc48 antibodies to determine optimal concentrations

    • Consider chemical crosslinking (e.g., DSP) for capturing transient interactions

    • Test both direct IP (anti-lub1) and reverse IP (anti-Cdc48) approaches

  • Controls and verification:

    • Include IgG isotype controls

    • Use Δlub1 and Cdc48 mutant strains as negative controls

    • Validate with recombinant proteins expressed in heterologous systems

  • Advanced approaches:

    • Sequential IP (tandem affinity purification) for higher specificity

    • Native gel electrophoresis followed by Western blotting

    • Size exclusion chromatography combined with immunodetection

How can researchers differentiate between specific and non-specific signals in lub1 immunoblotting?

Distinguishing specific from non-specific signals requires systematic controls:

  • Essential controls:

    • Δlub1 lysates as negative controls

    • Recombinant lub1 as positive controls

    • Secondary antibody-only controls to identify background signals

  • Signal validation approaches:

    • Peptide competition assays (pre-incubate antibody with immunizing peptide)

    • Use multiple antibodies targeting different lub1 epitopes

    • Compare signal patterns with orthogonal detection methods

  • Technical considerations:

    • Optimize blocking conditions (5% BSA often superior to milk for phospho-specific antibodies)

    • Test varying antibody dilutions (typically 1:500 to 1:5000 range)

    • Consider gradient gels for better resolution of the ~78 kDa lub1 protein

  • Data interpretation guidelines:

    • Specific lub1 signal should disappear in Δlub1 samples

    • Signal intensity should correlate with known expression levels

    • Compare molecular weight with predicted size (approximately 78 kDa for full-length lub1)

What considerations are important when using lub1 antibodies across different species?

Lub1 is evolutionarily conserved, with homologues in other organisms (e.g., Ufd3p/Doa1p in budding yeast and PLAP in humans) . When using lub1 antibodies across species:

  • Sequence homology analysis:

    • Perform sequence alignments to identify conserved regions

    • Generate phylogenetic trees to understand evolutionary relationships

    • Predict cross-reactivity based on epitope conservation

  • Cross-reactivity testing protocol:

    • Test antibodies on lysates from multiple species

    • Use recombinant proteins from different species as controls

    • Perform epitope mapping to identify conserved binding regions

  • Optimization strategies:

    • Adjust antibody concentrations based on binding affinity differences

    • Modify blocking and washing conditions for each species

    • Consider using different secondary antibodies optimized for each host species

  • Functional conservation considerations:

    • Compare phenotypes between species to validate functional homology

    • Use complementation studies to confirm functional equivalence

    • Design experiments to investigate species-specific differences in lub1 function

How can researchers investigate the relationship between lub1 and the ubiquitin-proteasome system using antibodies?

The relationship between lub1 and ubiquitin homeostasis can be further explored using antibody-based methods:

  • Co-localization studies:

    • Double immunofluorescence with lub1 and proteasome component antibodies

    • Super-resolution microscopy to examine spatial relationships

    • Live-cell imaging using fluorescently tagged proteins validated with antibodies

  • Ubiquitin dynamics analysis:

    • Immunoprecipitate lub1 and probe for ubiquitinated proteins

    • Use linkage-specific ubiquitin antibodies (K48, K63) to characterize modified proteins

    • Perform in vitro ubiquitination assays with recombinant components

  • Proteasome interaction studies:

    • Co-immunoprecipitation of lub1 with proteasome subunits

    • Proteasome activity assays in the presence/absence of lub1

    • Analyze effects of lub1 antibody addition on proteasome function in vitro

  • Stress response protocols:

    • Track changes in lub1-ubiquitin associations during stress responses

    • Monitor proteasome localization in wild-type versus Δlub1 cells under stress

    • Quantify ubiquitinated protein levels in response to lub1 manipulation

Experimental ApproachTechnical MethodExpected Outcome in Wild-typeExpected Outcome in Δlub1
Ubiquitin homeostasisWestern blot with anti-ubiquitinNormal levels of free and conjugated ubiquitinDepleted monoubiquitin and multiubiquitin
Proteasome functionFluorogenic substrate assayNormal proteolytic activityAberrant ubiquitin/proteasome-dependent proteolysis
Stress responseGrowth assay under stress conditionsNormal growthHypersensitivity to UV, heat, and chemical stressors
Cdc48 interactionCo-immunoprecipitationLub1-Cdc48 complex detectedNo Lub1 detected, altered Cdc48 interactions

How might lub1 antibodies be used to investigate conserved ubiquitin regulation across eukaryotes?

The conservation of lub1 across species suggests broader applications for lub1 antibodies:

  • Comparative biology approaches:

    • Test antibody cross-reactivity with homologues in diverse species

    • Investigate conservation of lub1-mediated ubiquitin regulation

    • Compare stress response mechanisms across evolutionary distance

  • Disease model applications:

    • Examine the role of human homologues in neurodegenerative diseases

    • Investigate connections to protein aggregation disorders

    • Study potential dysregulation in cancer models

  • Systems biology integration:

    • Map lub1 interaction networks across species

    • Identify conserved and divergent regulatory hubs

    • Develop predictive models of ubiquitin homeostasis

  • Technological approaches:

    • Apply CRISPR-based tagging validated with lub1 antibodies

    • Develop biosensors for monitoring lub1 activity in real-time

    • Implement antibody-based proteomics to map the "lub1-ome"

What novel antibody engineering approaches might improve lub1 antibody performance for challenging applications?

Advanced antibody engineering techniques can enhance lub1 antibody functionality:

  • Emerging antibody formats:

    • Single-domain antibodies (nanobodies) for improved intracellular delivery

    • Bispecific antibodies targeting lub1 and interaction partners simultaneously

    • Recombinant antibody fragments with enhanced tissue penetration

  • Computational design strategies:

    • Structure-guided epitope selection based on molecular modeling

    • Multi-objective optimization using linear programming

    • Machine learning approaches to predict optimal antibody sequences

  • Affinity maturation techniques:

    • Directed evolution using yeast or phage display

    • Rational design of complementarity-determining regions

    • Combinatorial approaches to identify optimal binding variants

  • Functional enhancement strategies:

    • Site-specific conjugation for reporter molecule attachment

    • pH-sensitive variants for endosomal escape

    • Thermostable derivatives for challenging experimental conditions

How could understanding lub1's role in stress response inform broader research on cellular resilience mechanisms?

Lub1's involvement in stress response pathways opens avenues for broader research:

  • Integrated stress response investigations:

    • Map lub1's position in the hierarchy of stress response pathways

    • Identify potential crosstalk between lub1-mediated and other stress responses

    • Develop models of cellular resilience incorporating ubiquitin homeostasis

  • Translational research directions:

    • Examine cellular protection mechanisms against proteotoxic stress

    • Investigate potential applications in neurodegenerative disease models

    • Explore connections to aging and longevity pathways

  • Experimental approaches:

    • Develop lub1 reporter systems for monitoring stress in real-time

    • Create cellular stress models with tunable lub1 expression

    • Implement high-content screening for modulators of lub1 function

  • Interdisciplinary applications:

    • Connect lub1 function to metabolic adaptation during stress

    • Investigate environmental influences on ubiquitin homeostasis

    • Develop mathematical models of cellular resilience incorporating lub1 activity

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.